Continuous Renal Replacement Therapy in Critically Ill Children

被引：4

作者：

Demirkol, Demet ^{[1
]}

机构：

[1] Istanbul Univ, Istanbul Fac Med, Dept Pediat Intens Care, Pediat Intens Care, Istanbul, Turkey

来源：

TURKISH ARCHIVES OF PEDIATRICS | 2022年 / 57卷 / 05期

关键词：

Sepsis; respiratory failure; extracorporeal treatment; ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMOFILTRATION; VASCULAR ACCESS; CATHETER; SEPSIS; ANTICOAGULATION; MULTICENTER; PREDILUTION; DYSFUNCTION; INITIATION;

D O I：

10.5152/TurkArchPediatr.2022.22082

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Continuous renal replacement therapy is an extracorporeal blood purification therapy that aims to support kidney and other organ functions over an extended period. The high-quality continuous renal replacement therapy requires understanding basic mechanisms of clearance, factors influencing these processes, and the appropriate selection of treatment candidates. This article reviews the different aspects of continuous renal replacement therapy in critically ill pediatric patients.

引用

页码：489 / 497

页数：9

共 59 条

[1]

[Anonymous], TURKIYEDE SUREKLI RE

[2] A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury [J].

Atan, Rafidah ;

Peck, Leah ;

Prowle, John ;

Licari, Elisa ;

Eastwood, Glenn M. ;

Storr, Markus ;

Goehl, Hermann ;

Bellomo, Rinaldo .

CRITICAL CARE MEDICINE, 2018, 46 (10) :E988-E994

[3] Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs [J].

Bai, Ming ;

Zhou, Meilan ;

He, Lijie ;

Ma, Feng ;

Li, Yangping ;

Yu, Yan ;

Wang, Pengbo ;

Li, Li ;

Jing, Rui ;

Zhao, Lijuan ;

Sun, Shiren .

INTENSIVE CARE MEDICINE, 2015, 41 (12) :2098-2110

[4]

Barbar SD, 2018, NEW ENGL J MED, V379, P1431, DOI [10.1056/NEJMoa1803213, 10.1056/nejmoa1803213]

[5] Assessment of a renal angina index for prediction of severe acute kidney injury in critically ill children: a multicentre, multinational, prospective observational study [J].

Basu, Rajit K. ;

Kaddourah, Ahmad ;

Goldstein, Stuart L. .

LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (02) :112-120

[6]

Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413

[7] Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose [J].

Bellomo, Rinaldo ;

Martensson, Johan ;

Lo, Serigne ;

Kaukonen, Kirsi-Maija ;

Cass, Alan ;

Gallagher, Martin .

BLOOD PURIFICATION, 2016, 41 (1-3) :11-17

[8]

Borg Roberta, 2017, J Intensive Care Soc, V18, P184, DOI 10.1177/1751143717695835

[9] Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk A Randomized Clinical Trial [J].

Choi, Ji-Young ;

Kang, Yun-Jeong ;

Jang, Hye Min ;

Jung, Hee-Yeon ;

Cho, Jang-Hee ;

Park, Sun-Hee ;

Kim, Yong-Lim ;

Kim, Chan-Duck .

MEDICINE, 2015, 94 (52)

[10] Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure [J].

Chua, Horng-Ruey ;

Baldwin, Ian ;

Bailey, Michael ;

Subramaniam, Ashwin ;

Bellomo, Rinaldo .

JOURNAL OF CRITICAL CARE, 2012, 27 (06)

← 1 2 3 4 5 6 →